New hope for severe hair loss: drug showdown begins
NCT ID NCT07406204
First seen Feb 13, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study tests two pills—tofacitinib and methotrexate—against each other in 78 adults with severe alopecia areata, including total scalp and body hair loss. Participants take one of the medicines for 12 weeks, and doctors measure hair regrowth using a standard scoring tool. The goal is to find which treatment works better for this autoimmune condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.